Presently, the prognostication and treatment for breast cancer relied primarily on several traditionally confirmed prognostic factors including tumor stage (TNM), tumor histological grade and lymph node status, as well as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor (EGF) receptor 2 (HER2) [4]. Here, ESR1 is linked to neoplasm.